Jin Tae Hong Selected Research

Neoplasm Metastasis (Metastasis)

9/2023	Modulatory effects of point-mutated IL-32θ (A94V) on tumor progression in triple-negative breast cancer cells.
6/2023	Anti‑tumor effects of an aqueous extract of Ecklonia cava in BALB/cKorl syngeneic mice using colon carcinoma CT26 cells.
1/2022	Falcarindiol Stimulates Apoptotic and Autophagic Cell Death to Attenuate Cell Proliferation, Cell Division, and Metastasis through the PI3K/AKT/mTOR/p70S6K Pathway in Human Oral Squamous Cell Carcinomas.
1/2022	A small molecule targeting CHI3L1 inhibits lung metastasis by blocking IL-13Rα2-mediated JNK-AP-1 signals.
1/2020	Chitinase 3 like 1 suppresses the stability and activity of p53 to promote lung tumorigenesis.
1/2019	Inhibition of Lung Tumor Development in ApoE Knockout Mice via Enhancement of TREM-1 Dependent NK Cell Cytotoxicity.
1/2019	Interleukin-32θ inhibits tumor-promoting effects of macrophage-secreted CCL18 in breast cancer.
10/2018	Deficiency of parkin suppresses melanoma tumor development and metastasis through inhibition of MFN2 ubiquitination.
1/2018	Suppression of metastasis through inhibition of chitinase 3-like 1 expression by miR-125a-3p-mediated up-regulation of USF1.
9/2014	Anti-angiogenic potential of an ethanol extract of Annona atemoya seeds in vitro and in vivo.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jin Tae Hong Research Topics

Disease

132	Neoplasms (Cancer) 04/2024 - 12/2002
55	Inflammation (Inflammations) 01/2024 - 11/2004
45	Alzheimer Disease (Alzheimer's Disease) 03/2024 - 05/2004
35	Neuroinflammatory Diseases 01/2022 - 01/2009
22	Colonic Neoplasms (Colon Cancer) 10/2017 - 02/2003
21	Lung Neoplasms (Lung Cancer) 04/2024 - 11/2012
16	Cognitive Dysfunction 01/2023 - 08/2008
16	Constipation 01/2022 - 11/2013
12	Neoplasm Metastasis (Metastasis) 09/2023 - 11/2008
12	Melanoma (Melanoma, Malignant) 06/2019 - 01/2012
11	Atopic Dermatitis (Atopic Eczema) 01/2024 - 07/2013
11	Arthritis (Polyarthritis) 01/2022 - 11/2004
9	Carcinogenesis 01/2024 - 12/2002
8	Neurodegenerative Diseases (Neurodegenerative Disease) 04/2024 - 01/2012
8	Memory Disorders (Memory Loss) 01/2020 - 01/2012
7	Breast Neoplasms (Breast Cancer) 11/2023 - 08/2007
7	Parkinson Disease (Parkinson's Disease) 01/2023 - 08/2015
7	Obesity 11/2022 - 09/2012
6	Insulin Resistance 02/2024 - 02/2017
6	Hyperplasia 11/2018 - 09/2007
6	Uterine Cervical Neoplasms (Cancer of the Cervix) 07/2017 - 03/2009
6	Prostatic Neoplasms (Prostate Cancer) 08/2011 - 02/2007
5	Atherosclerosis 01/2023 - 06/2008
5	Necrosis 02/2015 - 07/2010
5	Edema (Dropsy) 05/2014 - 11/2004
4	Sepsis (Septicemia) 12/2023 - 02/2015
4	Wounds and Injuries (Trauma) 02/2023 - 05/2017
4	Cardiovascular Diseases (Cardiovascular Disease) 01/2023 - 05/2007
4	Dementia (Dementias) 01/2022 - 01/2012
4	Amyloid Plaque 07/2021 - 02/2012
4	Stroke (Strokes) 03/2020 - 07/2009
4	Hypoxia (Hypoxemia) 01/2020 - 08/2013

Drug/Important Bio-Agent (IBA)

50	Proteins (Proteins, Gene)FDA Link 04/2024 - 10/2007
43	CytokinesIBA 01/2024 - 03/2009
38	NF-kappa B (NF-kB)IBA 01/2020 - 11/2004
24	LipopolysaccharidesIBA 12/2023 - 08/2008
19	Amyloid (Amyloid Fibrils)IBA 12/2021 - 01/2011
17	Amyloid beta-PeptidesIBA 08/2018 - 05/2004
15	DNA (Deoxyribonucleic Acid)IBA 01/2017 - 10/2007
14	Bee Venoms (Bee Venom)IBA 01/2022 - 11/2004
14	Ethanol (Ethyl Alcohol)IBA 01/2020 - 07/2009
13	Small Interfering RNA (siRNA)IBA 04/2024 - 10/2010
13	AntioxidantsIBA 01/2021 - 10/2007
12	phthalic anhydrideIBA 01/2024 - 04/2011
12	magnesium monoperoxyphthalateIBA 12/2023 - 11/2016
12	Peptides (Polypeptides)IBA 12/2021 - 05/2004
12	Death Domain ReceptorsIBA 07/2017 - 01/2012
11	Loperamide (Imodium)FDA LinkGeneric 01/2022 - 11/2013
11	thiacremononeIBA 07/2016 - 08/2007
10	LaxativesIBA 01/2021 - 11/2013
10	Peroxiredoxin VIIBA 01/2020 - 12/2013
10	4-O-methylhonokiolIBA 07/2015 - 07/2009
9	Snake Venoms (Snake Venom)IBA 01/2022 - 02/2007
9	Caspase 3 (Caspase-3)IBA 01/2021 - 01/2012
9	Therapeutic UsesIBA 03/2020 - 07/2013
9	Transcription Factors (Transcription Factor)IBA 03/2016 - 08/2007
8	ChemokinesIBA 09/2023 - 10/2009
8	Amyloid Precursor Protein Secretases (beta-Secretase)IBA 07/2021 - 01/2009
7	Phosphotransferases (Kinase)IBA 04/2024 - 12/2009
7	Glucose (Dextrose)FDA LinkGeneric 03/2023 - 09/2012
7	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2023 - 10/2005
7	ChitinasesIBA 01/2023 - 01/2018
7	Neuroprotective AgentsIBA 01/2023 - 05/2012
7	Transcription Factor AP-1 (Transcription Factor AP 1)IBA 01/2022 - 12/2002
7	MucinsIBA 01/2022 - 11/2013
7	LigandsIBA 01/2022 - 11/2003
7	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2021 - 06/2012
7	CC ChemokinesIBA 01/2019 - 01/2012
7	Docetaxel (Taxotere)FDA Link 07/2014 - 05/2009
7	obovatolIBA 07/2012 - 03/2008
6	1- Methyl- 4- phenyl- 1,2,3,6- tetrahydropyridine (MPTP)IBA 01/2023 - 08/2015
6	Interleukin-4 (Interleukin 4)IBA 12/2020 - 04/2011
6	Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA 01/2020 - 02/2003
6	Antineoplastic Agents (Antineoplastics)IBA 01/2019 - 11/2008
6	CarcinogensIBA 11/2018 - 02/2003
6	Presenilin-2IBA 01/2017 - 09/2005
6	Melitten (Melittin)IBA 01/2012 - 11/2004
5	STAT3 Transcription Factor (Signal Transducer and Activator of Transcription 3)IBA 12/2023 - 05/2012
5	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 03/2023 - 10/2010
5	LeptinIBA 01/2022 - 03/2015
5	Messenger RNA (mRNA)IBA 07/2021 - 09/2014
5	astaxanthine (astaxanthin)IBA 03/2020 - 01/2018
5	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2020 - 04/2014
5	Melanocyte-Stimulating Hormones (MSH)IBA 01/2019 - 06/2013
5	FlavonoidsIBA 05/2017 - 07/2012
5	Cisplatin (Platino)FDA LinkGeneric 01/2015 - 05/2009
5	TeaIBA 07/2013 - 10/2005
4	Phenol (Carbolic Acid)FDA Link 11/2023 - 11/2016
4	Biomarkers (Surrogate Marker)IBA 10/2022 - 01/2015
4	Dopamine (Intropin)FDA LinkGeneric 01/2022 - 04/2016
4	Interleukin-6 (Interleukin 6)IBA 07/2021 - 02/2015
4	Tannic Acid FDA Link 01/2021 - 01/2016
4	Cholinergic Agents (Cholinergics)IBA 01/2021 - 10/2018
4	Proliferating Cell Nuclear Antigen (PCNA)IBA 01/2021 - 04/2014
4	Galla RhoisIBA 01/2021 - 01/2016

Therapy/Procedure

18	Therapeutics 03/2024 - 08/2007
9	Immunotherapy 04/2024 - 07/2010
5	Aftercare (After-Treatment) 10/2018 - 11/2013
5	Traditional Medicine (Folk Remedies) 11/2017 - 08/2007
4	Drug Therapy (Chemotherapy) 01/2021 - 05/2009